ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Survival and pre-discharge outcomes of extremely preterm neonates: a single- center prospective cohort study from the United Arab Emirates.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDescribe survival and short-term outcomes of extremely low gestational age neonates (ELGANs) at a tertiary centre in United Arab Emirates (UAE) and to compare outcomes with regional and international data. STUDY
designProspective single-center cohort study with passive follow up of infants born between 22⁰⁄₇ and 26⁶⁄₇ weeks' gestation from 2019 to 2025. Survival to discharge and morbidities were evaluated.
resultsAmong 125 ELGANs, survival to discharge increased from 31% at 22 weeks to 88% at 26 weeks gestational age. Survival among peri-viable infants was higher than regional cohorts and comparable to high-income countries. Major morbidities among survivors included bronchopulmonary dysplasia (54%), intraventricular hemorrhage (53%), and retinopathy of prematurity requiring treatment (36%).
conclusionELGAN survival in this UAE center was comparable to international benchmarks, though morbidity remains substantial. Improved peri-viable survival compared with regional data may reflect impact of active perinatal care and supports its role in improving outcomes.
Identifiers
42477101What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.